Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Nov;147(5):1450–1455.

NF2 gene analysis distinguishes hemangiopericytoma from meningioma.

J T Joseph 1, D K Lisle 1, L B Jacoby 1, W Paulus 1, R Barone 1, M L Cohen 1, W H Roggendorf 1, J M Bruner 1, J F Gusella 1, D N Louis 1
PMCID: PMC1869503  PMID: 7485407

Abstract

The histogenesis of dural-based or "central" hemangiopericytomas (cHPCs) remains controversial. Some authors consider these tumors variants of meningiomas while others consider them akin to peripheral hemangiopericytomas (pHPCs). Meningiomas frequently have mutations in the neurofibromatosis 2 (NF2) gene, providing a molecular marker for meningiomas and other NF2-related tumors. We therefore analyzed the NF2 gene in cHPCs, pHPCs, and meningiomas to determine whether cHPCs are more similar at the molecular genetic level to meningiomas or pHPCs. Using paraffin-embedded archival material from 28 cHPCs (including three primary and recurrent tumors), 10 pHPCs, and 26 meningiomas, we scanned all 17 exons of the NF2 gene and flanking intronic sequences for mutations with single strand conformation polymorphism analysis and DNA sequencing. No NF2 mutations were found in either cHPCs or pHPCs, whereas 35% of meningiomas had NF2 gene alterations (P < 0.001). The NF2 gene mutations in meningiomas were all truncating mutations, consistent with previous studies. Our findings suggest that cHPCs are distinct from meningiomas at the molecular genetic level and support prior clinico-pathological data that distinguish these tumor-entities.

Full text

PDF
1450

Images in this article

1452Figure 1
on p.1452
1453Figure 2
on p.1453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaubal A., Paetau A., Zoltick P., Miettinen M. CD34 immunoreactivity in nervous system tumors. Acta Neuropathol. 1994;88(5):454–458. doi: 10.1007/BF00389498. [DOI] [PubMed] [Google Scholar]
  2. D'Amore E. S., Manivel J. C., Sung J. H. Soft-tissue and meningeal hemangiopericytomas: an immunohistochemical and ultrastructural study. Hum Pathol. 1990 Apr;21(4):414–423. doi: 10.1016/0046-8177(90)90204-i. [DOI] [PubMed] [Google Scholar]
  3. Forus A., Flørenes V. A., Maelandsmo G. M., Fodstad O., Myklebost O. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Genet Cytogenet. 1994 Dec;78(2):165–171. doi: 10.1016/0165-4608(94)90085-x. [DOI] [PubMed] [Google Scholar]
  4. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1991 Aug;1(1):34–38. doi: 10.1101/gr.1.1.34. [DOI] [PubMed] [Google Scholar]
  5. Henn W., Wullich B., Thönnes M., Steudel W. I., Feiden W., Zang K. D. Recurrent t(12;19)(q13;q13.3) in intracranial and extracranial hemangiopericytoma. Cancer Genet Cytogenet. 1993 Dec;71(2):151–154. doi: 10.1016/0165-4608(93)90022-e. [DOI] [PubMed] [Google Scholar]
  6. Henson J. W., Schnitker B. L., Correa K. M., von Deimling A., Fassbender F., Xu H. J., Benedict W. F., Yandell D. W., Louis D. N. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol. 1994 Nov;36(5):714–721. doi: 10.1002/ana.410360505. [DOI] [PubMed] [Google Scholar]
  7. Herath S. E., Stalboerger P. G., Dahl R. J., Parisi J. E., Jenkins R. B. Cytogenetic studies of four hemangiopericytomas. Cancer Genet Cytogenet. 1994 Feb;72(2):137–140. doi: 10.1016/0165-4608(94)90129-5. [DOI] [PubMed] [Google Scholar]
  8. Horten B. C., Urich H., Rubinstein L. J., Montague S. R. The angioblastic meningioma: a reappraisal of the nosological problem. Light-, electron-microscopic, tissue, and organ culture observations. J Neurol Sci. 1977 Apr;31(3):387–410. doi: 10.1016/0022-510x(77)90217-9. [DOI] [PubMed] [Google Scholar]
  9. Jacoby L. B., MacCollin M., Louis D. N., Mohney T., Rubio M. P., Pulaski K., Trofatter J. A., Kley N., Seizinger B., Ramesh V. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet. 1994 Mar;3(3):413–419. doi: 10.1093/hmg/3.3.413. [DOI] [PubMed] [Google Scholar]
  10. Lekanne Deprez R. H., Bianchi A. B., Groen N. A., Seizinger B. R., Hagemeijer A., van Drunen E., Bootsma D., Koper J. W., Avezaat C. J., Kley N. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet. 1994 Jun;54(6):1022–1029. [PMC free article] [PubMed] [Google Scholar]
  11. Limon J., Rao U., Dal Cin P., Gibas Z., Sandberg A. A. Translocation (13;22) in a hemangiopericytoma. Cancer Genet Cytogenet. 1986 Apr 15;21(4):309–318. doi: 10.1016/0165-4608(86)90211-6. [DOI] [PubMed] [Google Scholar]
  12. Lindblom A., Ruttledge M., Collins V. P., Nordenskjöld M., Dumanski J. P. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer. 1994 Feb 1;56(3):354–357. doi: 10.1002/ijc.2910560310. [DOI] [PubMed] [Google Scholar]
  13. Louis D. N., Ramesh V., Gusella J. F. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol. 1995 Apr;5(2):163–172. doi: 10.1111/j.1750-3639.1995.tb00590.x. [DOI] [PubMed] [Google Scholar]
  14. Louis D. N., Rubio M. P., Correa K. M., Gusella J. F., von Deimling A. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol. 1993 Sep;52(5):507–515. doi: 10.1097/00005072-199309000-00009. [DOI] [PubMed] [Google Scholar]
  15. Louis D. N., von Deimling A., Seizinger B. R. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol. 1992 Oct;141(4):777–782. [PMC free article] [PubMed] [Google Scholar]
  16. Luna E. J., Hitt A. L. Cytoskeleton--plasma membrane interactions. Science. 1992 Nov 6;258(5084):955–964. doi: 10.1126/science.1439807. [DOI] [PubMed] [Google Scholar]
  17. Mandahl N., Orndal C., Heim S., Willén H., Rydholm A., Bauer H. C., Mitelman F. Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas. Cancer. 1993 May 15;71(10):3009–3013. doi: 10.1002/1097-0142(19930515)71:10<3009::aid-cncr2820711020>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  18. Mashal R. D., Koontz J., Sklar J. Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases. Nat Genet. 1995 Feb;9(2):177–183. doi: 10.1038/ng0295-177. [DOI] [PubMed] [Google Scholar]
  19. Muller J., Mealey J., Jr The use of tissue culture in differentiation between angioblastic meningioma and hemangiopericytoma. J Neurosurg. 1971 Mar;34(3):341–348. doi: 10.3171/jns.1971.34.3.0341. [DOI] [PubMed] [Google Scholar]
  20. Rempel S. A., Schwechheimer K., Davis R. L., Cavenee W. K., Rosenblum M. L. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res. 1993 May 15;53(10 Suppl):2386–2392. [PubMed] [Google Scholar]
  21. Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993 Jun 10;363(6429):515–521. doi: 10.1038/363515a0. [DOI] [PubMed] [Google Scholar]
  22. Ruttledge M. H., Sarrazin J., Rangaratnam S., Phelan C. M., Twist E., Merel P., Delattre O., Thomas G., Nordenskjöld M., Collins V. P. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 1994 Feb;6(2):180–184. doi: 10.1038/ng0294-180. [DOI] [PubMed] [Google Scholar]
  23. Seizinger B. R., de la Monte S., Atkins L., Gusella J. F., Martuza R. L. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5419–5423. doi: 10.1073/pnas.84.15.5419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sreekantaiah C., Bridge J. A., Rao U. N., Neff J. R., Sandberg A. A. Clonal chromosomal abnormalities in hemangiopericytoma. Cancer Genet Cytogenet. 1991 Jul 15;54(2):173–181. doi: 10.1016/0165-4608(91)90205-9. [DOI] [PubMed] [Google Scholar]
  25. Theaker J. M., Gatter K. C., Esiri M. M., Fleming K. A. Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study. J Clin Pathol. 1986 Apr;39(4):435–439. doi: 10.1136/jcp.39.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  27. Wellenreuther R., Kraus J. A., Lenartz D., Menon A. G., Schramm J., Louis D. N., Ramesh V., Gusella J. F., Wiestler O. D., von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol. 1995 Apr;146(4):827–832. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES